Selank vs Semax

Selank is a synthetic heptapeptide derived from tuftsin, an endogenous immunomodulatory peptide produced in the spleen. Developed at the Institute of Molecular Genetics in Russia, Selank has been extensively studied for its anxiolytic and nootropic properties through GABAergic and serotonergic modulation. Unlike benzodiazepines, Selank does not produce sedation or dependence in preclinical models, making it a unique tool for anxiety and cognition research. Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment, modified with a Pro-Gly-Pro tail for enhanced metabolic stability. Originally developed for stroke research at the Russian Academy of Sciences, Semax acts through BDNF upregulation and melanocortin receptor signaling without engaging adrenal corticosteroid pathways. It is widely studied in neuroprotection, ischemic injury, and cognitive enhancement models.

Selank

Origin Tuftsin-derived (spleen)
Primary Mechanism GABAergic & serotonergic modulation
Research Focus Anxiety, cognition, immunomodulation
Administration Routes Studied Intranasal, intraperitoneal
Key Biomarkers BDNF, serotonin metabolites, GABA-A binding
Sedation Profile No sedation in preclinical models

Semax

Origin ACTH(4-10) derivative
Primary Mechanism BDNF upregulation, melanocortin signaling
Research Focus Neuroprotection, ischemic injury, cognition
Administration Routes Studied Intranasal, intraperitoneal
Key Biomarkers BDNF, TrkB, c-Fos, Arc
Sedation Profile No sedation; mild stimulant in some models

The Verdict

Selank and Semax are both Russian-developed neuropeptides with non-overlapping mechanisms. Selank is the more direct tool for anxiolytic and immune-modulation research, working through GABA and serotonin pathways without sedation. Semax is the stronger choice for neuroprotection and stroke recovery research due to its BDNF-driven mechanism. Both are studied via intranasal administration and are often considered together in cognition research, though they are mechanistically distinct.

Explore These Products

Selank

A synthetic analog of tuftsin studied for its anxiolytic and nootropic effects through GABA modulation and immunomodulatory pathways.

View Details →

Semax

A synthetic peptide derived from ACTH fragment 4-10, studied for cognitive enhancement, neuroprotection, and BDNF upregulation in research models.

View Details →

Selank vs Semax — FAQ

Are Selank and Semax related?
They are both Russian-developed peptides studied at the Institute of Molecular Genetics, but they have completely different origins and mechanisms. Selank is derived from tuftsin, while Semax is based on the ACTH(4-10) fragment.
Can they be studied together?
Yes. Their mechanisms are non-overlapping, making them suitable for combined cognitive and neuroprotective research protocols.
Do they cause sedation?
Neither peptide produces sedation in published preclinical models, distinguishing them from traditional anxiolytics like benzodiazepines.
What is the regulatory status?
Both Selank and Semax are sold as research-use-only compounds for in-vitro and preclinical study models.

References

Primary sources for key clinical and regulatory claims on this page.

  1. Anxiolytic activity of peptide drug Selank — PubMed / Bull Exp Biol Med . Primary preclinical reference for Selank anxiolytic activity through GABAergic modulation.
  2. Semax, an ACTH(4-10) analogue with nootropic properties — PubMed / Neurosci Behav Physiol . Foundational source describing Semax neuroprotective and BDNF-upregulating mechanisms.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides Category
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now